Paper41579216
Delphi panel consensus on genetic testing for prostate cancer in Australia: Whom to test and how?
Edmunds K and 8 others. Fam Cancer, 2026. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. Delphi panel consensus on genetic testing for prostate cancer in Australia: Whom to test and how? Papers, record 41579216. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41579216
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Delphi panel consensus on genetic testing for prostate cancer in Australia: Whom to test and how?
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Prostatic Neoplasms | Major topic |
| Genetic Testing | Major topic |
| Humans | |
| Male | |
| Australia | |
| Delphi Technique | |
| Genetic Counseling | |
| Consensus | |
| Genetic Predisposition to Disease |
Source PubMed
References41
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 30730552 | Prevalence of Germline Variants in Prostate Cancer and Implications for Current Genetic Testing Guidelines. | JAMA Oncol | 2019 | https://conductscience.org/library/papers/30730552 | PubMed |
| 2 | 32960678 | Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline PART II. | J Urol | 2021 | https://conductscience.org/library/papers/32960678 | PubMed |
| 3 | 35251382 | Prostate cancer treatment costs increase more rapidly than for any other cancer-how to reverse the trend? | EPMA J | 2022 | https://conductscience.org/library/papers/35251382 | PubMed |
| 4 | 40417742 | The cost-utility of targeted germline BRCA testing in localized prostate cancer followed by cascade testing first-degree relatives with pathogenic variants. | Genet Med | 2025 | https://conductscience.org/library/papers/40417742 | PubMed |
| 5 | 32593798 | Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. | Ann Oncol | 2020 | https://conductscience.org/library/papers/32593798 | PubMed |
| 6 | 28655541 | Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017. | Eur Urol | 2018 | https://conductscience.org/library/papers/28655541 | PubMed |
| 7 | 39700441 | Implementation of Universal Germline Genetic Testing Into Standard of Care for Patients With Prostate Cancer: The Time Is Now. | JCO Oncol Pract | 2025 | https://conductscience.org/library/papers/39700441 | PubMed |
| 8 | 32001144 | Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019. | Eur Urol | 2020 | https://conductscience.org/library/papers/32001144 | PubMed |
| 9 | 33916521 | Hereditary Prostate Cancer: Genes Related, Target Therapy and Prevention. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/33916521 | PubMed |
| 10 | 38977196 | The Cost-Effectiveness of Germline BReast CAncer Gene Testing in Metastatic Prostate Cancer Followed by Cascade Testing of First-Degree Relatives of Mutation Carriers. | Value Health | 2024 | https://conductscience.org/library/papers/38977196 | PubMed |
| 11 | 19346959 | Interest in genetic testing among affected men from hereditary prostate cancer families and their unaffected male relatives. | Genet Med | 2009 | https://conductscience.org/library/papers/19346959 | PubMed |
| 12 | 31078660 | The REDCap consortium: Building an international community of software platform partners. | J Biomed Inform | 2019 | https://conductscience.org/library/papers/31078660 | PubMed |
| 13 | 35597177 | Implementation of preventive and predictive BRCA testing in patients with breast, ovarian, pancreatic, and prostate cancer: a position paper of Italian Scientific Societies. | ESMO Open | 2022 | https://conductscience.org/library/papers/35597177 | PubMed |
| 14 | 35924163 | Genetic Testing and Its Clinical Application in Prostate Cancer Management: Consensus Statements from the Hong Kong Urological Association and Hong Kong Society of Uro-Oncology. | Front Oncol | 2022 | https://conductscience.org/library/papers/35924163 | PubMed |
| 15 | 24581294 | Defining consensus: a systematic review recommends methodologic criteria for reporting of Delphi studies. | J Clin Epidemiol | 2014 | https://conductscience.org/library/papers/24581294 | PubMed |
| 16 | 32960679 | Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline PART I. | J Urol | 2021 | https://conductscience.org/library/papers/32960679 | PubMed |
| 17 | 32356468 | Thematic analysis of qualitative data: AMEE Guide No. 131. | Med Teach | 2020 | https://conductscience.org/library/papers/32356468 | PubMed |
| 18 | 34519462 | Update Swiss guideline for counselling and testing for predisposition to breast, ovarian, pancreatic and prostate cancer. | Swiss Med Wkly | 2021 | https://conductscience.org/library/papers/34519462 | PubMed |
| 19 | 39787437 | Germline and Somatic Genomic Testing for Metastatic Prostate Cancer: ASCO Guideline. | J Clin Oncol | 2025 | https://conductscience.org/library/papers/39787437 | PubMed |
| 20 | 40030090 | Perceptions and Use of Germline Genetic Testing Among Patients With Prostate Cancer. | JCO Oncol Pract | 2025 | https://conductscience.org/library/papers/40030090 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42047879 | From "who to test" to "who benefits": equity-by-design guardrails for prostate cancer germline testing at scale. | Fam Cancer | 2026 | https://conductscience.org/library/papers/42047879 |
Source PubMed
Genes11
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ATM | 472 | PubTator's text mining | https://conductscience.org/library/genes/472 | NCBI Gene |
| BRCA1 | 672 | PubTator's text mining | https://conductscience.org/library/genes/672 | NCBI Gene |
| BRCA2 | 675 | PubTator's text mining | https://conductscience.org/library/genes/675 | NCBI Gene |
| CHEK2 | 11200 | PubTator's text mining | https://conductscience.org/library/genes/11200 | NCBI Gene |
| EPCAM | 4072 | PubTator's text mining | https://conductscience.org/library/genes/4072 | NCBI Gene |
| KLK3 | 354 | PubTator's text mining | https://conductscience.org/library/genes/354 | NCBI Gene |
| MLH1 | 4292 | PubTator's text mining | https://conductscience.org/library/genes/4292 | NCBI Gene |
| MSH2 | 4436 | PubTator's text mining | https://conductscience.org/library/genes/4436 | NCBI Gene |
| MSH6 | 2956 | PubTator's text mining | https://conductscience.org/library/genes/2956 | NCBI Gene |
| PARP1 | 142 | PubTator's text mining | https://conductscience.org/library/genes/142 | NCBI Gene |
| PMS2 | 5395 | PubTator's text mining | https://conductscience.org/library/genes/5395 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41579216
GET https://conductscience.org/api/papers/v1/41579216/references?page=2